Loading…
Company showcased advancements during a conference call.
iBio, Inc. (IBIO) announced on June 24, 2025, the presentation of its next-generation pipeline candidates targeting obesity and cardiometabolic conditions during a conference call.
The company highlighted its progress and future plans for these innovative therapeutic approaches.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.